Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial's eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 421 - 440 of 522 trials
Titlesort icon Investigator Disease(s)
A Phase I Study of PLX3397 in Patients with Advanced Solid Tumors
[Protocol 12-156]
Tap, William
  • Sarcomas
    • Soft Tissue Sarcoma
  • Thyroid Cancer
A Phase I Study of PF-05082566 Alone in Patients with Advanced Cancer, and in Combination with Rituximab in Patients with Non-Hodgkin Lymphoma
[Protocol 11-085]
Segal, Neil
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I Study of Panitumumab in Children with Solid Tumors
[Protocol 08-020]
Meyers, Paul
A Phase I Study of Palbociclib in Younger Patients with Recurrent or Persistent Brain or Spinal Cord Tumors
Newly Diagnosed & Relapsed/Refractory
[Protocol 14-252]
Gilheeney, Stephen
  • Pediatric Brain Tumors
    • Brain Cancer
    • CNS Cancer
A Phase I Study of Oral LEE011 in Patients with Advanced Solid Tumors or Lymphomas
[Protocol 10-211]
Gerecitano, John
  • Lymphoma
A Phase I Study of Oral CLR457 in Patients with Advanced Solid Tumors
[Protocol 14-155]
Fury, Matthew
  • Solid Tumors
A Phase I Study of Oral AG-120 to Treat Advanced Acute Myeloid Leukemia or Myelodysplastic Syndromes with an IDH1 Mutation
[Protocol 14-052]
Stein, Eytan
  • Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
    • Myelodysplastic Syndrome
A Phase I Study of Oral AG-120 in Patients with Advanced Solid Tumors, Including Glioma, with an IDH1 Mutation
Relapsed/Refractory
[Protocol 14-068]
Mellinghoff, Ingo
  • Brain Tumors, Primary
    • Gliomas
  • Solid Tumors
A Phase I Study of Nivolumab with Combination Chemotherapy for Patients with Previously Untreated Stage IIIB or IV Non-Small Cell Lung Cancer
[Protocol 11-189]
Hellmann, Matthew
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase I Study of Nivolumab (BMS-936558) in Patients with Relapsed or Refractory Hematologic Cancers
Relapsed/Refractory
[Protocol 12-142]
Lesokhin, Alexander
  • Hematology
    • Multiple Myeloma
  • Leukemia
    • Chronic Myelocytic Leukemia
  • Lymphoma
    • Hodgkin's Disease
    • Non-Hodgkin's Lymphoma
A Phase I Study of NEOD001 in Patients with Light Chain Amyloidosis
[Protocol 12-280]
Landau, Heather
  • Hematology
    • Hematologic Disorders
    • Hematologic Malignancies
A Phase I Study of MT-3724 for the Treatment of Relapsed B-cell Non-Hodgkin Lymphoma
[Protocol 14-265]
Hamlin, Paul
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I Study of MOXR0916 in Patients with Advanced Cancers
[Protocol 14-250]
Lesokhin, Alexander
  • Solid Tumors
A Phase I Study of Mogamulizumab with Tremelimumab or MEDI4736 in Patients with Advanced Cancers
[Protocol 14-269]
Zamarin, Dmitriy
  • Solid Tumors
A Phase I Study of Mogamulizumab (KW-0761) in Patients with Advanced Solid Tumors
[Protocol 14-135]
Wolchok, Jedd
  • Solid Tumors
A Phase I Study of Modified T Cells Targeted to CD19-Positive Acute Lymphoblastic Leukemia Relapsing After Allogeneic Stem Cell Transplantation
[Protocol 11-038]
Curran, Kevin
  • Leukemia
    • Acute Lymphoblastic Leukemia
A Phase I Study of MK-1775 with Radiation Therapy and Temozolomide in Patients with Newly Diagnosed Glioblastoma
Newly Diagnosed
[Protocol 13-161]
Kaley, Thomas
  • Brain Tumors, Primary
    • Gliomas
A Phase I Study of MEDI4736 in Patients with Advanced Solid Tumors
[Protocol 12-179]
Segal, Neil
  • Colorectal Cancer
  • Kidney Cancer
  • Lung Cancer, Non-Small Cell
  • Melanoma
A Phase I Study of MEDI4736 in Patients with Advanced Solid Tumors
[Protocol 13-198]
Callahan, Margaret
  • Cervical Cancer
  • Colorectal Cancer
  • Head & Neck Cancer
  • Kidney Cancer
  • Lung Cancer, Non-Small Cell
  • Ovarian Cancer
  • Solid Tumors
A Phase I Study of MEDI4736 and Tremelimumab in Patients with Advanced Head and Neck Cancer
[Protocol 14-234]
Fury, Matthew
  • Head & Neck Cancer